Exploring Living With Hcc Stories From The Frontlines Q A
Exploring Living With Hcc Stories From The Frontlines Q A reveals several interesting facts.
- Anthony El-Khoueiry, MD, associate professor of clinical medicine, Keck School of Medicine, USC Norris Comprehensive Cancer ...
- Richard Kim, MD, assistant professor of oncology, University of South Florida College of Medicine, medical oncologist, ...
- Tony Villiotti, liver cancer survivor and founder of advocacy organization NASH kNOWledge (also known as Liver Education ...
- David J. Pinato, MD, PhD, clinical senior lecturer in medical oncology, clinician scientist, consultant medical oncologist, ...
- Panelists Richard S. Finn, MD, and Arndt Vogel, MD, PhD, discuss the management of side effects with sorafenib in
In-Depth Information on Living With Hcc Stories From The Frontlines Q A
Panelists Richard S. Finn, MD; Arndt Vogel, MD, PhD; and Jordi Bruix, MD, provide insight on the recent noninferiority clinical trial ... Andrew Zhu, MD, PhD, director of Liver Cancer Research and Medicine at Massachusetts General Hospital, shares his advice on ... Paul shares his journey of being diagnosed with Michael A. Morse, MD, FACP, discusses how the specific goals of a patient are factors in determining the appropriate
Richard S. Finn, MD, professor of Clinical Medicine Division of Hematology/ Oncology UCLA David Geffen School of Medicine ...
Stay tuned for more updates related to Living With Hcc Stories From The Frontlines Q A.
